SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis.
Jie LiMing-Han LiTian-Tian WangXiao-Ning LiuXiao-Ting ZhuYun-Zhang DaiKe-Chao ZhaiYong-da LiuJia-Li LinRui-Liang GeShu-Han SunFang WangJi-Hang YuanPublished in: British journal of cancer (2021)
SLC38A4 downregulation was identified as a novel oncofetal event, and SLC38A4 was identified as a novel tumour suppressor in HCC.